MyFinsight
Home
Blog
About
Contact
crsp: the balance sheet
Download
Download image
Total property and
equipment, gross
$206,444K
Prepaid expenses and
other current assets
$13,382K
Marketable securities
$1,629,213K
Cash and cash
equivalents
$286,497K
Other non-current
assets
$24,308K
Operating lease assets
$134,659K
Restricted cash
$8,006K
Marketable securities,
non-current
$28,412K
Property and equipment,
net
$120,831K
Total current assets
$1,929,092K
Accumulated depreciation
$85,613K
Total assets
$2,245,308K
Total liabilities and
shareholders equity
$2,245,308K
Total shareholders'
equity
$1,915,982K
Total liabilities
$329,326K
Accumulated deficit
-$1,816,938K
Treasury shares, at cost,
125,316 and 170,316...
$60K
Accumulated other
comprehensive income
$4,986K
Additional paid-in capital
$3,724,981K
Other non-current
liabilities
$5,278K
Operating lease
liabilities, net of current...
$192,768K
Deferred revenue,
non-current
$12,323K
Total current
liabilities
$118,957K
Common shares, chf 0.03
nominal value,...
$3,013K
Operating lease
liabilities
$18,256K
Accrued tax liabilities
$3,426K
Deferred revenue,
current
$1,295K
Accrued expenses
$84,182K
Accounts payable
$11,798K
Back
Back
Balance Sheet
source: myfinsight.com
CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics AG (CRSP)